10Y UST4.94%-1.40%30Y MTG6.95%+2.81%SOFR3.85%+6.35%VNQ$92.91-0.96%XLRE$42.53-0.95%FED FUNDS3.88%+6.89%
Real Estate Trail
Institutional Press Wire
Connect CRE · Boston

Roche, Genentech Cut Ribbon on Allston Innovation Center

Via Connect CRE · September 18, 2026
Compiled by Real Estate Trail Editorial · September 18, 2026

Why this matters

Commercial real estate continues to digest a multi-year reset in cost of capital. Transaction velocity is below the 2019-2021 trend but improving, cap rates have stabilized across most stabilized property types, and the bid-ask gap has narrowed materially in the past two quarters. Sponsors with permanent capital and operating platforms have an advantage in the current execution environment. Boston life sciences absorption has moderated from its 2021-2022 pace, and the market is working through a meaningful Cambridge sublease overhang. Multifamily and trophy office remain durable. The next twelve months will continue to reward underwriting discipline and operational sophistication over balance-sheet aggression.

Editorial analysis · Real Estate Trail Editorial

On the RET wire

Computed from Real Estate Trail’s own tracked coverage

Excerpt from Connect CRE:
Genentech, a member of the Roche Group, held the grand opening of the Roche Genentech Innovation Center Boston in Allston. Roche and Genentech have signed a 10-year lease for the 95,000-square-foot center, which has c…
Read the full article at Connect CRE

External link. Real Estate Trail does not republish source content.

Related coverageBoston